nateglinide


Also found in: Dictionary, Wikipedia.

nateglinide

 [nah-teg´lĭ-nīd]
an antidiabetic agent that lowers blood glucose concentrations by stimulating the release of insulin from pancreatic islet beta cells; administered orally in the treatment of type 2 diabetes mellitus, either alone or in combination with metformin.

nateglinide

/na·teg·li·nide/ (nah-teg´lĭ-nīd) an agent that stimulates release of insulin from pancreatic islet beta cells, used in the treatment of type 2 diabetes.

nateglinide

(nə-tĕg′lĭ-nīd′)
n.
An oral hypoglycemic drug, C19H27NO3, that stimulates the release of insulin from the pancreas and is used to treat type 2 diabetes.

nateglinide

[näteg′lĭ-nīd]
an antidiabetic agent that lowers blood glucose concentrations by stimulating the release of insulin from pancreatic islet beta cells. It is administered orally in the treatment of type 2 diabetes mellitus, either alone or in combination with metformin.
References in periodicals archive ?
Complete report on Nateglinide market spread across 155 pages providing 5 company profiles and 150 tables and figures is available at http://www.
5% methylcellulose, GK rats, model control), nateglinide (50 mg/kg, GK rats, positive control) or AA (50 mg/kg, GK rats, sample) by oral gavage twice daily just before each meal for 12 weeks.
On the fifth day of treatment, nateglinide therapy was discontinued because the two-hour postprandial glucose levels were were found to be between 70 and 80 mg/dl.
Repaglinide (Gluconorm[R]) and nateglinide (Starlix[R])are both approved to be used in combination with metformin (Novartis Pharmaceuticals, 2009; Novo Nordisk, 2010).
Using the Entelos Metabolism PhysioLab platform, a mathematical model of whole-body human metabolism, a total of 133 "virtual" patients with type 2 diabetes were modeled for the effects of treatment with pioglitazone (45 mg/day), subcutaneous insulin (40 U 70/30 regular or lente twice daily), or nateglinide (120 mg three times daily).
com/research/vxcx3f/investigation) has announced the addition of the "Investigation Report on China's Nateglinide Market, 2010-2019" report to their offering.
Their study focused on a re-analysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcome Research (NAVIGATOR) trial.
Indeed, the magnitude of the effect is in the range of glucose-lowering medications that are taken before meals, such as nateglinide and acarbose, said Dr.
Both pioglitazone and nateglinide improve glucose tolerance, but only pioglitazone improved insulin sensitivity and reduced insulin levels.
Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.
Nateglinide (Starlix) and repaglinide (Prandin), insulin secretagogues, have very short elimination half-lives (1-1.